These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24073707)

  • 41. The role of mast cells and angiogenesis in well-differentiated oral squamous cell carcinoma.
    Tahir A; Nagi AH; Ullah E; Janjua OS
    J Cancer Res Ther; 2013; 9(3):387-91. PubMed ID: 24125971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.
    Kang CJ; Lin CY; Wang HM; Fan KH; Ng SH; Lee LY; Chen IH; Huang SF; Liao CT; Yen TC
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e223-30. PubMed ID: 21640500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with oral squamous cell carcinoma.
    Vucicević Boras V; Cikes N; Lukać J; Virag M; Cekić-Arambasin A
    Minerva Stomatol; 2005 Oct; 54(10):569-73. PubMed ID: 16224376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metallothionein-1 genotypes in the risk of oral squamous cell carcinoma.
    Zavras AI; Yoon AJ; Chen MK; Lin CW; Yang SF
    Ann Surg Oncol; 2011 May; 18(5):1478-83. PubMed ID: 21128001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P53-mutation in smears of oral squamous cell carcinoma.
    Friedrich RE; Giese M; Riethdorf S; Loning T
    Anticancer Res; 2000; 20(6D):4927-30. PubMed ID: 11326641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Cancer; 2007 Aug; 110(3):564-71. PubMed ID: 17577219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salivary concentration of TNFalpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma.
    SahebJamee M; Eslami M; AtarbashiMoghadam F; Sarafnejad A
    Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E292-5. PubMed ID: 18449112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Squamous cell carcinoma of the oral cavity, maxillary antrum and lip in a Zimbabwean population: a descriptive epidemiological study.
    Chidzonga MM; Mahomva L
    Oral Oncol; 2006 Feb; 42(2):184-9. PubMed ID: 16256417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients.
    Zhong LP; Chen GF; Xu ZF; Zhang X; Ping FY; Zhao SF
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):566-70. PubMed ID: 16053879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the oral bacterial flora: current status and future directions.
    Parahitiyawa NB; Scully C; Leung WK; Yam WC; Jin LJ; Samaranayake LP
    Oral Dis; 2010 Mar; 16(2):136-45. PubMed ID: 19627515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of antioxidant enzymes activity and the concentration of uric acid in the saliva of patients with oral cavity cancer, odontogenic cysts and healthy subjects.
    Giebułtowicz J; Wroczyński P; Samolczyk-Wanyura D
    J Oral Pathol Med; 2011 Oct; 40(9):726-30. PubMed ID: 21501233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Saliva cytoanalysis: an aid in early diagnosis of exfoliate oral malignancies.
    Muñoz Noya RA
    Rev Odontol P R; 1978; 15(1):12-24. PubMed ID: 296543
    [No Abstract]   [Full Text] [Related]  

  • 54. In vivo Raman spectroscopy of oral buccal mucosa: a study on malignancy associated changes (MAC)/cancer field effects (CFE).
    Singh SP; Sahu A; Deshmukh A; Chaturvedi P; Krishna CM
    Analyst; 2013 Jul; 138(14):4175-82. PubMed ID: 23392131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight into the Microbiome-Treatment Axis.
    Sami A; Elimairi I; Stanton C; Ross RP; Ryan CA
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Alexander Mosse C; Morcos M; Hopper C
    Lasers Surg Med; 2011 Aug; 43(6):463-9. PubMed ID: 21761416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anaerobic bacterial communities associated with oral carcinoma: Intratumoral, surface-biofilm and salivary microbiota.
    Minarovits J
    Anaerobe; 2021 Apr; 68():102300. PubMed ID: 33246097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of microflora associated with oral malignancy.
    Nagy K; Szöke I; Sonkodi I; Nagy E; Mari A; Szolnoky G; Newman HN
    Oral Oncol; 2000 Jan; 36(1):32-6. PubMed ID: 10889916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.